SYK Stryker Corporation

Q3 2025 10-Q

Filed: Oct 31, 2025Period ending Sep 30, 2025

Health Care

Surgical & Medical Instruments & ApparatusSEC EDGAR

Stryker Corporation (SYK) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 31, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue $6.06B Q3 2025, up 10.3% vs $5.49B Q3 2024; nine months $17.95B, up 11.1% vs $16.16B prior year
• Operating margin 18.7% Q3 2025 vs 19.7% YoY; nine months margin 17.2% vs 19.2% YoY - adjusted margins improved to 25.6% Q3 and 24.7% YTD

+3 more insights

Risk Factors

• No material changes to risk factors from 2024 10-K for fiscal 2025 10-Q

Quarterly Financial Summary
XBRL

Revenue

$6.1B

▲ +10.2% YoY▲ +0.6% QoQ

Net Income

$859M

▲ +3.0% YoY▼ -2.8% QoQ

Net Margin

14.2%

▼ -100bp YoY▼ -50bp QoQ

Source: XBRL data from Stryker Corporation Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Stryker Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.